Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dupilumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience
Cosimo Galletti, Martina Ragusa, Federico Sireci, et al.
American Journal of Otolaryngology (2023) Vol. 45, Iss. 1, pp. 104106-104106
Open Access | Times Cited: 19

Showing 19 citing articles:

Mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience
Cosimo Galletti, Federico Sireci, Giovanna Stilo, et al.
American Journal of Otolaryngology (2025) Vol. 46, Iss. 1, pp. 104597-104597
Open Access | Times Cited: 1
Effect of Dupilumab in CRSwNP Sinonasal Outcomes from Real Life Studies: A Systematic Review with Meta-analysis
Miguel Rodriguez-Iglesias, Christian Calvo‐Henríquez, Daniel Martín-Jiménez, et al.
Current Allergy and Asthma Reports (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Effectiveness and safety profile of mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a tertiary care
Cosimo Galletti, Francesco Ciodaro, María Antonietta Barbieri, et al.
American Journal of Otolaryngology (2024) Vol. 45, Iss. 4, pp. 104329-104329
Closed Access | Times Cited: 5
Biological therapy in Chronic rhinosinusitis with nasal polyps
Zeyi Jin, Bing Yan, Luo Zhang, et al.
Expert Review of Clinical Immunology (2025)
Closed Access
Real-world Outcomes Following Biologic Initiation in US Patients with Chronic Rhinosinusitis with Nasal Polyps
Anju T. Peters, Xiaohui Zhao, Aimee M. Near, et al.
Advances in Therapy (2025)
Open Access
Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Meta‐Analysis of Real‐World Evidence
Shiru Cai, Shenglong Xu, Yan Zhao, et al.
Allergy (2025)
Open Access
Chinese Position Paper on Biologic Therapy for Chronic Rhinosinusitis With Nasal Polyps
Mu Xian, Bing Yan, Xicheng Song, et al.
Allergy (2025)
Open Access
The Morphology of Nasal Polyps in Different Age Groups: Histopathological Features
Vincenzo Fiorentino, Maurizio Martini, Cosimo Galletti, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 4, pp. 414-414
Open Access | Times Cited: 3
Efficacy of dupilumab for severe chronic rhinosinusitis with nasal polyps and asthma
Tomoko Tajiri, Motohiko Suzuki, Hirono Nishiyama, et al.
Annals of Allergy Asthma & Immunology (2024) Vol. 133, Iss. 5, pp. 550-558.e2
Closed Access | Times Cited: 3
Rheumatic adverse events associated with biologic therapy for chronic rhinosinusitis: A systematic review and meta‐analysis
Jenny B. Xiao, Helen Hsiao, Carlos Khalil, et al.
International Forum of Allergy & Rhinology (2024) Vol. 14, Iss. 10, pp. 1618-1633
Open Access | Times Cited: 3
'Efficacy of biologics in NSAID-ERD: United airways from the nose to the bronchi'
Kathleen M. Buchheit, Elke Vandewalle, Hester Beatrice Emilie Elzinga, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 11, pp. 2917-2932
Closed Access | Times Cited: 2
Trends in dupilumab persistence among patients with chronic rhinosinusitis with nasal polyps
Taylor Stack, Saif Zaidi, Theresa A. Dickerson, et al.
Rhinology online (2024) Vol. 7, Iss. 7, pp. 69-74
Open Access | Times Cited: 1
Secukinumab (Anti‐IL‐17A Therapeutic Antibody) Improves Clinical Outcome for a Mixed Endotype CRS
Mihkel Plaas, Agnieska Brazovskaja, Kai Kisand, et al.
Clinical Case Reports (2024) Vol. 12, Iss. 12
Closed Access | Times Cited: 1
Biologic Therapies across Nasal Polyp Subtypes
Kody G. Bolk, Sarah K. Wise
Journal of Personalized Medicine (2024) Vol. 14, Iss. 4, pp. 432-432
Open Access
Efectividad real de la terapia biológica en el tratamiento de pacientes con rinosinusitis crónica con poliposis nasosinusal
Cristina García-García, Ithzel María Villarreal, Adriana Pardo-Maza, et al.
Revista ORL (2024) Vol. 15, Iss. 2, pp. e31902-e31902
Open Access
ChatGPT as a New Tool to Select a Biological for Chronic Rhino Sinusitis with Polyps, “Caution Advised” or “Distant Reality”?
Federico Sireci, Francesco Lorusso, Angelo Immordino, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 6, pp. 563-563
Open Access
Prevalence and factors associated with olfactory impairment among patients with acne treated with oral isotretinoin: a cross-sectional study
Rogério Nabor Kondo, Hélio Amante Miot, Elouise Zwirtes Frare, et al.
Brazilian Journal of Otorhinolaryngology (2024) Vol. 90, Iss. 5, pp. 101461-101461
Open Access
Olfactory Dysfunction in Chronic Rhinosinusitis with Nasal Polyps: Effect of Treatment with Emphasis on Biological Therapy
Josje Janna Otten, Wytske J. Fokkens, Sietze Reitsma
Current Allergy and Asthma Reports (2024) Vol. 25, Iss. 1
Closed Access
A case of prolonged remission after discontinuation of biological therapy in a patient with severe uncontrolled chronic rhinosinusitis with nasal polyps
M. A. Budkovaia, Sergey Ryazantsev, S. A. Rebrova
Russian Bulletin of Otorhinolaryngology (2024) Vol. 89, Iss. 6, pp. 99-99
Closed Access
Page 1

Scroll to top